Literature DB >> 1354394

A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents.

A Surprenant1, D A Horstman, H Akbarali, L E Limbird.   

Abstract

The alpha 2A-adrenergic receptor (adrenoceptor) was stably expressed in AtT20 mouse pituitary tumor cells; adrenoceptor agonists inhibited adenylyl cyclase, inhibited voltage-dependent calcium currents, and increased inwardly rectifying potassium currents. An aspartic acid residue (Asp79) highly conserved among guanine nucleotide-binding protein (G protein)-coupled receptors was mutated to asparagine; in cells transfected with the mutant alpha 2-receptor, agonists inhibited adenylyl cyclase and calcium currents but did not increase potassium currents. Because distinct G proteins appear to couple adrenoceptors to potassium and calcium currents, the present findings suggest that the mutant alpha 2-adrenoceptor cannot achieve the conformation necessary to activate G proteins that mediate potassium channel activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354394     DOI: 10.1126/science.1354394

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  Effect of chronic clonidine treatment on transmitter release from sympathetic varicosities of the guinea-pig vas deferens.

Authors:  D Knight; T C Cunnane; N A Lavidis
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo.

Authors:  P P Lakhlani; L B MacMillan; T Z Guo; B A McCool; D M Lovinger; M Maze; L E Limbird
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Authors:  Yonghua Zhang; Harold K Kimelberg
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

Review 4.  Functional domains of the gonadotropin-releasing hormone receptor.

Authors:  S C Sealfon; R P Millar
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

5.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

6.  Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine.

Authors:  A B Malmberg; L R Hedley; J R Jasper; J C Hunter; A I Basbaum
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding.

Authors:  J Nardone; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.

Authors:  Christopher M Tan; Matthew H Wilson; Leigh B MacMillan; Brian K Kobilka; Lee E Limbird
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-30       Impact factor: 11.205

9.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

10.  Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization.

Authors:  Roujian Lu; Yong Li; Youwen Zhang; Yunjia Chen; Angela D Shields; Danny G Winder; Timothy Angelotti; Kai Jiao; Lee E Limbird; Yi Zhou; Qin Wang
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.